BAC
Bank of America Corporation
BAC has the edge over JRVR overall, supported by stronger fundamentals and lower modeled downside.
JRVR
James River Group Holdings, Ltd.
JRVR trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
JRVR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
JRVR's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like JRVR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
JRVR PE Valuation
JRVR has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over JRVR on the outlook, with more favorable earnings and revenue expectations.
JRVR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect JRVR's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over JRVR on earnings quality, reporting a profit while its opponent remains loss making.
JRVR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.91 | — |
| Q3 2026 | -$3.62 | -$1.38 |
| Q2 2026 | $0.44 | +$3.76 |
| Q1 2026 | $0.40 | +$3.65 |
| Q4 2025 | $0.79 | +$3.85 |
| Q3 2025 | -$2.24 | +$1.81 |
| Q2 2025 | -$3.32 | -$0.82 |
| Q1 2025 | -$3.25 | -$0.97 |
| Q4 2024 | -$3.06 | -$0.61 |
JRVR is still losing money, but less than at its worst: $3.62 per share over the past year, against $4.94 at its worst in late 2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over JRVR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over JRVR on profitability, with a higher operating margin.
JRVR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $147.7M | -14% |
| Q2 2026 | $161.3M | -7.7% |
| Q1 2026 | $151.4M | -12% |
| Q4 2025 | $167.7M | +32% |
| Q3 2025 | $172.7M | -9.8% |
| Q2 2025 | $174.8M | -7.1% |
| Q1 2025 | $172.3M | -14% |
| Q4 2024 | $126.7M | -42% |
JRVR's revenue fell from its 2019 peak and has held roughly level since: $148M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -128% | -129 points |
| Q2 2026 | 5.2% | +1 points |
| Q1 2026 | -7% | -16 points |
| Q4 2025 | 15% | +72 points |
| Q3 2025 | 1.5% | +29 points |
| Q2 2025 | 4.2% | -6.5 points |
| Q1 2025 | 9.3% | -7.1 points |
| Q4 2024 | -57% | -70 points |
JRVR's operating margin was −128% last quarter, down 129 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over JRVR on cash generation, producing positive trailing cash flow while its opponent burns cash.
JRVR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$39.8M | -218% |
| Q2 2026 | -$5.9M | -124% |
| Q1 2026 | -$766K | +$51.9M |
| Q4 2025 | -$29.3M | -718% |
| Q3 2025 | $33.7M | +$304.4M |
| Q2 2025 | $24.7M | +$34M |
| Q1 2025 | -$52.7M | -326% |
| Q4 2024 | $4.7M | +$17.7M |
JRVR's free cash flow was −$76M over the past year, against $10M the year before. Free cash flow isn't a meaningful measure for financial services companies like JRVR.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over JRVR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
JRVR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -623K shares |
| 1 year | -0.8% | -387K shares |
| 3 years | +22% | +8.5M shares |
| 5 years | +34% | +11.8M shares |
| Available history | +51% | +15.7M shares |
JRVR has 46M diluted shares, down 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | $1.5M |
| Q4 2022 | $363,000 |
| Q3 2022 | — |
| Q2 2022 | $19,000 |
| Q1 2022 | $922,000 |
| Q4 2021 | $315,000 |
| Q3 2021 | — |
| Q2 2021 | $209,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
JRVR Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
JRVR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.4 | Neutral |
| Stochastic | 26.1 | Neutral |
JRVR's weekly RSI is 30 (neutral) and its Stochastic is 26 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
JRVR PE vs Financial Services Sector
| Metric | JRVR | Sector median | Relative |
|---|---|---|---|
| PE | 8.8x | 13x | 32% below |
| PE % | 22 | 63 | 41 pts below |
JRVR has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over JRVR on trend strength, trading above more of its moving averages.
JRVR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.67 | 14% below |
| 20 week MA | $4.05 | 22% below |
| 50 week MA | $5.12 | 39% below |
| 100 week MA | $5.13 | 39% below |
| 200 week MA | $8.78 | 64% below |
JRVR is in a downtrend: it's below all five of its weekly moving averages, and 64% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over JRVR on returns for 2026, with the stronger performance.
JRVR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.5 | $48.9 | +18% |
| 2021 | $48.9 | $27.1 | -44% |
| 2022 | $27.1 | $22.1 | -19% |
| 2023 | $22.1 | $9.24 | -58% |
| 2024 | $9.24 | $4.84 | -48% |
| 2025 | $4.84 | $6.39 | +32% |
| 2026 YTD | $6.39 | $3.14 | -51% |
JRVR has finished lower in four of the last six years. It's down 51% so far in 2026.